InvestorsHub Logo
Followers 18
Posts 1015
Boards Moderated 0
Alias Born 02/13/2013

Re: None

Friday, 04/14/2017 1:26:48 AM

Friday, April 14, 2017 1:26:48 AM

Post# of 733
http://www.rightdiagnosis.com/v/vitiligo/stats-country.htm

Future markets for vitiligo - view into the future of clinuvel as long as the admission studies are successful and market approval will get achieved. The figures are calculated by extrapolation of US-data (not based on country-specific data sources) ...


What do you think this will bring to us? Does it take still much longer now before afamelanotide is granted for Vitiligo now it's granted for EPP within the EU?

Clinuvel a safe investment.

Clinuvel isn't a start-up anymore, it's doing business. It's a grown-up Biotech company. Clinuvel undervalued.


Afamelanotide for EPP, granted in the EU. The only thing the FDA has to do is signing. The EMA did already the homework for them. What's keeping it up! There is absolutely no reason for that anymore.
It's better they fuse together.

Still $0,10 behind the australian closingprice yesterday and $0,25 behind UR9 at the Frankfurter borse! It's time America wakes up, the train is leaving.